Skip to main content
SpringerLink
Log in

Screening for Colorectal cancer

  • Chapter
Evaluation of Cancer Screening

Part of the book series: Focus on Cancer ((3292))

  • 58 Accesses

Abstract

Carcinoma of the large bowel is a common condition in developed countries accounting for 12% of cancer registrations and of cancer deaths in England and Wales. In both sexes it is the third commonest cause of cancer death, after lung and prostate cancer in men, and breast and lung cancer in women. In 1992, 8749 men and 8654 women died from colorectal cancer [44, 45].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adami H-O (1988) Aspects of descriptive epidemiology and survival in colorectal cancer. Scand J Gastroenterol. Suppl 149:6–20.

    Article  CAS  Google Scholar 

  2. Ahlquist DA, McGill DB, Schwartz S, Taylor WF, Owen RA (1985) Fecal blood levels in health and disease. A study using Hemoquant. Gastroenterology 82:891–898.

    Google Scholar 

  3. Armstrong B, Doll R (1975) Environmental factors and cancer incidence in different countries, with special reference to dietary practices. Int J Cancer 15:617–631.

    Article  PubMed  CAS  Google Scholar 

  4. Atkin WS, Cuzick J, Northover JMA, Whynes DK (1993) Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 341:736–740.

    Article  PubMed  CAS  Google Scholar 

  5. Atkin WS, Morson BC, Cuzick J (1992) Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326:658–662.

    Article  PubMed  CAS  Google Scholar 

  6. Bingham SA (1990) Diet and large bowel cancer. J R Soc Med 83:420–422.

    PubMed  CAS  Google Scholar 

  7. Black RJ, Sharp L, Kendrick SW (1993) Trends in cancer survival in Scotland, 1968–1990. Information and Statistics Division, ISD Publications, Edinburgh.

    Google Scholar 

  8. Burkitt DP (1969) Related disease — related cause. Lancet ii:1229–1231.

    Article  Google Scholar 

  9. Church TR, Mandel JS, Bond JH et al. (1991) Colon cancer control study: status and current issues. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer screening. UICC project on evaluation of screening for cancer. Cambridge University Press, Cambridge, pp 83–105.

    Google Scholar 

  10. Clark JC, Collan Y, Eide TJ et al. (1985) Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. Int J Cancer 36:179–186.

    Article  PubMed  CAS  Google Scholar 

  11. Dales LG, Friedman GD, Collen MF (1979) Evaluating periodic multiphasic health checkups: a controlled study. J Chron Dis 32:385–404.

    Article  PubMed  CAS  Google Scholar 

  12. Doran J, Hardcastle JD (1982) Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing. Br J Surg 69:711–713.

    Article  PubMed  CAS  Google Scholar 

  13. Donohue JH, Nelson H (1992) The current status of adjuvant therapy for colon cancer. Adv Surg 25:223–257.

    PubMed  CAS  Google Scholar 

  14. Eide TJ (1983) Remnants of adenomas in colorectal carcinomas. Cancer 51:1866–1872.

    Article  PubMed  CAS  Google Scholar 

  15. Eide TJ (1986) Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer 38:173–176.

    Article  PubMed  CAS  Google Scholar 

  16. Farrands PA, Hardcastle JD (1983) Accuracy of occult blood tests over a six-day period. Clin Oncol 9:217–225.

    PubMed  CAS  Google Scholar 

  17. Farrands PA, Hardcastle JD (1984) Colorectal screening by a self-completion questionnaire. Gut 25:445–447.

    Article  PubMed  CAS  Google Scholar 

  18. Farrands PA, Hardcastle JD, Chamberlain J (1984) Factors affecting compliance with screening for colorectal cancer. Community Med 6:12–19.

    PubMed  CAS  Google Scholar 

  19. Gilbertsen VA, Nelms JM (1978) The prevention of invasive cancer of the rectum. Cancer 41:1137–1139.

    Article  PubMed  CAS  Google Scholar 

  20. Hardcastle JD, Chamberlain J, Sheffield J et al. (1989) Randomised controlled trial of faecal occult blood screening for colorectal cancer. Results of the first 107 349 subjects. Lancet i:l160–1164.

    Google Scholar 

  21. Hill MJ (1989) Experimental studies of fat, fibre and calories in carcinogenesis. In: Miller AB, Veronesi U (eds) Diet and the aetiology of cancer. European School of Oncology Monograph. Springer-Verlag, Berlin, pp 31–38.

    Google Scholar 

  22. Hobbs FDR, Cherry RC, Fielding JWL, Pike L, Holder R (1992) Acceptability of opportunistic screening for occult gastrointestinal blood loss. Br Med J 304:483–486.

    Article  CAS  Google Scholar 

  23. Hoff G, Foerster A, Vatn MH et al. (1986) Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection. Scand J Gastroenterol 21:853–862.

    Article  PubMed  CAS  Google Scholar 

  24. Holliday HW, Hardcastle JD (1979) Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet i:309–311.

    Article  Google Scholar 

  25. Jahn H, Jorgensen OD, Kronborg O et al. (1992) Can Haemoccult II replace colon-oscopy in surveillance after radical surgery for colorectal cancer and after poly-pectomy? Dis Colon Rectum 35:253–256.

    Article  PubMed  CAS  Google Scholar 

  26. Jorgensen OD, Kronborg O, Fenger C (1993) The Funen adenoma follow-up study. Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol 28:869–874.

    Article  PubMed  CAS  Google Scholar 

  27. Kee F, Wilson RH, Gilliland R et al. (1992) Changing site distribution of colorectal cancer. Br Med J 305:158.

    Article  CAS  Google Scholar 

  28. Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C (1988) Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27 700 subjects. Cancer 62:645–651.

    Article  PubMed  CAS  Google Scholar 

  29. Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O (1989) Repeated screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 24:599–606.

    Article  PubMed  CAS  Google Scholar 

  30. Kronborg O, Fenger C, Sondergaard O, Pedersen KM, Olsen J (1987) Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomised study at Funen in Denmark. Scand J Gastroenterol 22:677–686.

    Article  PubMed  CAS  Google Scholar 

  31. Kronborg O, Fenger C, Olsen J (1991) Interim report on a randomised trial of screening for colorectal cancer with Hemoccult-II. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer screening. UICC project on evaluation of screening for cancer. Cambridge University Press, Cambridge, pp 126–130.

    Google Scholar 

  32. Lancet (1992) Screening for colorectal cancer by stool DNA analysis (Editorial). Lancet 339:1141–1142.

    Article  Google Scholar 

  33. Limberg B (1990) Diagnosis of large bowel tumours by colonic sonography. Lancet 335:144–146.

    Article  PubMed  CAS  Google Scholar 

  34. Macrae FA, St. John DJ (1982) Relationship between patterns of bleeding and Haemoccult sensitivity in patients with colorectal cancers or adenomas. Gastro-enterology 82:891.

    CAS  Google Scholar 

  35. Mandel JS, Bond JH, Church TR et al. (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 328:1365–1371.

    Article  PubMed  CAS  Google Scholar 

  36. Manning AM, Williams AC, Game SM, Paraskeva C (1991) Differential sensitivity of human colonie adenoma and carcinoma cells to transforming growth factor β (TGF-β): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene 6:1471–1476.

    PubMed  CAS  Google Scholar 

  37. Mant D, Fitzpatrick R, Hogg A et al. (1990) Experiences of patients with false positive results from colorectal cancer screening. Br J Gen Pract 40:423–425.

    PubMed  CAS  Google Scholar 

  38. Maule WF (1994) Screening for colorectal cancer by nurse endoscopists. N Engl J Med 330:183–187.

    Article  PubMed  CAS  Google Scholar 

  39. Miller AB (1988) Review of sigmoidoscopic screening for colorectal cancer. In: Chamberlain J, Miller AB (eds) Screening for gastrointestinal cancer. International Union Against Cancer, Hans Huber, Toronto, pp 3–8.

    Google Scholar 

  40. Morson BC (1976) Genesis of colorectal cancer. Clin Gastroenterol 5:505–524.

    PubMed  CAS  Google Scholar 

  41. Murakam R, Tsukama H, Kanamori S et al. (1990) Natural history of colorectal polyps and the effect of polypectomy on occurrence of subsequent cancer. Int J Cancer 46:159–164.

    Article  Google Scholar 

  42. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84:1572–1575.

    Article  PubMed  CAS  Google Scholar 

  43. Nichols S, Koch E, Lallemand RC et al. (1986) Randomised trial of compliance with screening for colorectal cancer. Br Med J 293:107–110.

    Article  CAS  Google Scholar 

  44. Office of Population Censuses and Surveys (1993) Mortality statistics, 1992. Series DH2, No. 19. HMSO, London.

    Google Scholar 

  45. Office of Population Censuses and Surveys (1993) Cancer statistics. Registrations of cancer diagnosed in 1987, England and Wales. Series MBI, No. 20. HMSO, London.

    Google Scholar 

  46. Osmond C, Gardner M, Acheson ED, Adelstein AM (1983) Trends in cancer mortality 1951–1980. Office of Population Censuses and Surveys, Series DH, No. 11. HMSO, London.

    Google Scholar 

  47. Prorok PC, Byar DP, Smart CR, Baker SG, Connor RJ (1991) Evaluation of screening for prostate, lung, and colorectal cancers. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer screening. UICC project on evaluation of screening for cancer. Cambridge University Press, Cambridge, pp 300–320.

    Google Scholar 

  48. Pye G, Christie M, Chamberlain J, Moss SM, Hardcastle JD (1988) A comparison of methods for increasing compliance within a general practitioner-based screening project for colorectal cancer and the effect on practitioner workload. J Epidemiol Community Health 42(1):66–71.

    Article  PubMed  CAS  Google Scholar 

  49. Robinson MHE, Thomas WM, Hardcastle JD, Chamberlain J, Mangham CM (1993) Change towards earlier stage at presentation of colorectal cancer. Br J Surg 80:1610–1612.

    Article  PubMed  CAS  Google Scholar 

  50. Robinson MHE, Marks CG, Farrands PA, Thomas WM, Hardcastle JD (1994) Population screening for colorectal cancer: comparison between a guaiac and immunological faecal occult blood test. Br J Surg 81:448–451.

    Article  PubMed  CAS  Google Scholar 

  51. Robinson MHE, Kronborg O, Williams CB et al. (1995) Faeeal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia. Br J Surg 82:318–320.

    Article  PubMed  CAS  Google Scholar 

  52. St John DJB, Young GP, Alexeyeff MA, Deacon MC et al. (1993) Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 104:1661–1668.

    PubMed  CAS  Google Scholar 

  53. Sauar J, Hoff G, Hausken T et al. (1992) Colonoscopic screening examination of relatives of patients with colorectal cancer II, relations between tumour characteristics and the presence of polyps. Scand J Gastroenterol 27:667–672.

    Article  PubMed  CAS  Google Scholar 

  54. Selby JV, Friedman GD, Collen MF (1988) Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente multiphasic evaluation study. J Clin Epidemiol 41(5):427–434.

    Article  PubMed  CAS  Google Scholar 

  55. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326:653–657.

    Article  PubMed  CAS  Google Scholar 

  56. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1993) Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 118:1–6.

    CAS  Google Scholar 

  57. Sidransky D, Tokino T, Hamilton S et al. (1992) Identification of ras oncogene mutations in the stool of patients with curable colorectal tumours. Science 256:102–105.

    Article  PubMed  CAS  Google Scholar 

  58. Silman AJ, Mitchell P, Nicholls RJ et al. (1983) Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms. Br J Surg 70:721–724.

    Article  PubMed  CAS  Google Scholar 

  59. Stower MJ, Hardcastle JD (1985) Five year survival of 1115 patients with colorectal cancer. Eur J Surg Oncol 11:119–123.

    PubMed  CAS  Google Scholar 

  60. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL (1987) Natural history of untreated colonic polyps. Gastroenterology 93:1009–1013.

    PubMed  CAS  Google Scholar 

  61. Thomas WM, Hardcastle JD (1991) An update on the Nottingham trial of faecal occult blood screening for colorectal carcinoma. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer screening. UICC project on evaluation of screening for cancer. Cambridge University Press, Cambridge, pp 106–115.

    Google Scholar 

  62. Thomas WM, Hardcastle JD, Jackson J, Pye G (1992) Chemical and immunological testing for faecal occult blood: a comparison of two tests in symptomatic patients. Br J Cancer 65:618–620.

    Article  PubMed  CAS  Google Scholar 

  63. US Congress, Office of Technology Assessment (1990) Costs and effectiveness of colorectal cancer screening in the elderly — background paper, OTA-BP-H-74. US Government Printing Office, Washington, D.C.

    Google Scholar 

  64. Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colorectal tumour development. N Engl J Med 319:525–532.

    Article  PubMed  CAS  Google Scholar 

  65. Wahrendorf J, Robra B-P, Wiebelt H, Oberhausen R, Willand M, Dhom G (1993) Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 2:221–227.

    Article  PubMed  CAS  Google Scholar 

  66. Walker A, Whynes DK, Chamberlain JO, Hardcastle JD (1991) The cost of screening for colorectal cancer. J Epidemiol and Community Health 45:220–224.

    Article  CAS  Google Scholar 

  67. Weiler D, Moss J, Hiller J, Edwards J, Thomas D (1994) Screening for colorectal cancer — what are the costs? Int J Tech Ass Health Care.

    Google Scholar 

  68. Williams AR, Balasooriya BD, Day DW (1982) Polyps and cancer in the large bowel: a necropsy study in Liverpool. Gut 23:835–842.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Jocelyn Chamberlain
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cancer Screening Evaluation Unit, Section of Epidemiology, Institute of Cancer Research, Block D, Cotswold Road, Sutton, Surrey, SM2 5NG, UK

    Jocelyn Chamberlain  & Sue Moss  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag London Limited

About this chapter

Cite this chapter

Chamberlain, J. (1996). Screening for Colorectal cancer. In: Chamberlain, J., Moss, S. (eds) Evaluation of Cancer Screening. Focus on Cancer. Springer, London. https://doi.org/10.1007/978-1-4471-3044-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3044-4_4

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-19957-1

  • Online ISBN: 978-1-4471-3044-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation